Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial
Hung-Sheng Lin, Pei-Hsun Sung, Shu-Hua Huang, Wei-Che Lin, John Y. Chiang, Ming-Chun Ma, Yi-Ling Chen, Kuan-Hung Chen, Fan-Yen Lee, Sheung-Fat Ko, Hon-Kan Yip · 2024
Read Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial by Hung-Sheng Lin, Pei-Hsun Sung, Shu-Hua Huang, Wei-Che Lin, John Y. Chiang, Ming-Chun Ma, Yi-Ling Chen, Kuan-Hung Chen, Fan-Yen Lee, Sheung-Fat Ko, Hon-Kan Yip (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11577584.txt.
Description
Hung-Sheng Lin and ten co-authors present a trial from twenty twenty-four on stem cell care for acute stroke. Patients got their own CD34 cells, drawn from their blood, fed through a neck artery to the stroke zone. The phase two trial ran from twenty eighteen to twenty twenty-two. Close to thirty patients were split by lot into cell care and best drug care.
The cell route proved safe in full, with no tumors seen in long follow up. Stroke scale scores fell more by one and three months in the cell group. Brain blood flow at six months was higher in that group too. Growth signals and vessel growth skill in the blood rose after care. The team says the route is safe and may help.
Catalog record
| CREATOR | Hung-Sheng Lin, Pei-Hsun Sung, Shu-Hua Huang, Wei-Che Lin, John Y. Chiang, Ming-Chun Ma, Yi-Ling Chen, Kuan-Hung Chen, Fan-Yen Lee, Sheung-Fat Ko, Hon-Kan Yip |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |